AU4371799A - Lysine containing peptides for treatment of heart disease - Google Patents

Lysine containing peptides for treatment of heart disease

Info

Publication number
AU4371799A
AU4371799A AU43717/99A AU4371799A AU4371799A AU 4371799 A AU4371799 A AU 4371799A AU 43717/99 A AU43717/99 A AU 43717/99A AU 4371799 A AU4371799 A AU 4371799A AU 4371799 A AU4371799 A AU 4371799A
Authority
AU
Australia
Prior art keywords
peptides
present
treatment
heart disease
cardiac
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43717/99A
Other languages
English (en)
Inventor
Romano Deghenghi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to AU12706/00A priority Critical patent/AU768516B2/en
Publication of AU4371799A publication Critical patent/AU4371799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU43717/99A 1998-06-03 1999-05-28 Lysine containing peptides for treatment of heart disease Abandoned AU4371799A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU12706/00A AU768516B2 (en) 1998-06-03 1999-11-11 Treatment of tumors by administration of growth hormone releasing compounds and their antagonists

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09089955 1998-06-03
US09/089,955 US5932548A (en) 1998-06-03 1998-06-03 Lysine containing peptides for treatment of heart disease
PCT/EP1999/003731 WO1999062539A1 (en) 1998-06-03 1999-05-28 Lysine containing peptides for treatment of heart disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU12706/00A Division AU768516B2 (en) 1998-06-03 1999-11-11 Treatment of tumors by administration of growth hormone releasing compounds and their antagonists

Publications (1)

Publication Number Publication Date
AU4371799A true AU4371799A (en) 1999-12-20

Family

ID=22220375

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43717/99A Abandoned AU4371799A (en) 1998-06-03 1999-05-28 Lysine containing peptides for treatment of heart disease

Country Status (11)

Country Link
US (1) US5932548A (https=)
EP (2) EP1082128B1 (https=)
JP (1) JP2002516872A (https=)
AT (1) ATE314083T1 (https=)
AU (1) AU4371799A (https=)
CA (1) CA2330567A1 (https=)
DE (1) DE69929188T2 (https=)
DK (1) DK1082128T3 (https=)
ES (1) ES2259834T3 (https=)
PT (1) PT1082128E (https=)
WO (1) WO1999062539A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1783222E (pt) 1998-10-23 2012-07-26 Kirin Amgen Inc Péptidos diméricos de trombopoietina que simulam a ligação ao receptor mpl e têm actividade trombopoiética
US7488590B2 (en) 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
US20030130185A1 (en) * 2000-09-29 2003-07-10 David Bar-Or Metal-binding compounds and uses therefor
US7632803B2 (en) * 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US7592304B2 (en) 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US6211156B1 (en) * 1999-11-10 2001-04-03 Asta Medica A.G. Peptides for treatment of erectile dysfunction
JP3498041B2 (ja) 2000-05-29 2004-02-16 科研製薬株式会社 プラルモレリン含有点鼻用製剤
AU2001274601A1 (en) * 2000-06-23 2002-01-02 Kaken Pharmaceutical Co., Ltd. Preventives or remedies for heart failure
US20030055003A1 (en) * 2001-07-19 2003-03-20 David Bar-Or Use of copper chelators to inhibit the inactivation of protein C
TWI331922B (en) * 2002-08-09 2010-10-21 Ipsen Pharma Sas Growth hormone releasing peptides
BRPI0410505A (pt) * 2003-05-07 2006-06-20 Dmi Biosciences Inc métodos e produtos para cuidados orais
EA011879B1 (ru) 2004-09-24 2009-06-30 Эмджин Инк. МОЛЕКУЛЫ С МОДИФИЦИРОВАННЫМ Fc ФРАГМЕНТОМ
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
GB0603295D0 (en) 2006-02-18 2006-03-29 Ardana Bioscience Ltd Methods and kits
US9283260B2 (en) 2006-04-21 2016-03-15 Amgen Inc. Lyophilized therapeutic peptibody formulations
WO2007127457A2 (en) * 2006-04-28 2007-11-08 The Administrators Of The Tulane Educational Fund Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof
TW200916113A (en) * 2007-08-08 2009-04-16 Sod Conseils Rech Applic Method for inhibiting inflammation and pro-inflammatory cytokine/chemokine expression using a ghrelin analogue
GB2454549B (en) * 2007-09-25 2009-09-23 Medical & Pharm Ind Tech & Dev Uses of 2-[piperidinyl]methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one for providing an anti-allergic effect and histamine H1 receptor antagonism effect
US8476408B2 (en) * 2008-06-13 2013-07-02 Alize Pharma Sas Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease
EP2341942A1 (en) 2008-09-19 2011-07-13 Nektar Therapeutics Polymer conjugates of therapeutic peptides
US9724381B2 (en) 2009-05-12 2017-08-08 The Administrators Of The Tulane Educational Fund Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof
RU2404793C1 (ru) 2009-06-04 2010-11-27 Общество с ограниченной ответственностью Био Пептид Стимулятор половой, сексуальной и репродуктивной функции
RU2507212C3 (ru) 2012-03-28 2022-05-04 Общество С Ограниченной Ответственностью "Айвикс" Способ получения рекомбинантного пептида и полученный пептид
RU2626002C1 (ru) 2016-10-24 2017-07-21 Общество С Ограниченной Ответственностью "Айвикс" Новая группа пептидов для лечения женской сексуальной дисфункции

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668254A (en) * 1990-05-11 1997-09-16 Romano Deghenghi D-2-alkyl-tryptophan and peptides containing same
US5661122A (en) * 1994-04-15 1997-08-26 Genentech, Inc. Treatment of congestive heart failure
JP3810083B2 (ja) * 1994-09-27 2006-08-16 アーダナ・バイオサイエンス・リミテツド 成長因子の放出を促進し得る２−アルキルトリプトファン含有ペプチド化合物
US5798337A (en) * 1994-11-16 1998-08-25 Genentech, Inc. Low molecular weight peptidomimetic growth hormone secretagogues
IT1277113B1 (it) * 1995-12-20 1997-11-04 Romano Deghenghi Composti oligopeptidici contenenti d-2-alchiltriptofano in grado di promuovere la liberazione dell'ormone della crescita
SE9703929D0 (sv) * 1996-11-22 1997-10-28 Pharmacia & Upjohn Ab Therapeutical use and method
US5798102A (en) * 1997-03-04 1998-08-25 Milkhaus Laboratory, Inc. Treatment of cardiomyopathy
ZA987383B (en) * 1997-08-19 2000-02-17 Lilly Co Eli Treatment of congestive heart failure with growth hormone secretagogues.

Also Published As

Publication number Publication date
DE69929188T2 (de) 2006-08-17
CA2330567A1 (en) 1999-12-09
HK1035863A1 (en) 2001-12-14
ATE314083T1 (de) 2006-01-15
JP2002516872A (ja) 2002-06-11
EP1082128A1 (en) 2001-03-14
DE69929188D1 (de) 2006-02-02
EP1082128B1 (en) 2005-12-28
DK1082128T3 (da) 2006-04-10
WO1999062539A1 (en) 1999-12-09
PT1082128E (pt) 2006-05-31
EP1616571A2 (en) 2006-01-18
ES2259834T3 (es) 2006-10-16
US5932548A (en) 1999-08-03
EP1616571A3 (en) 2008-08-13

Similar Documents

Publication Publication Date Title
AU4371799A (en) Lysine containing peptides for treatment of heart disease
CA1330037C (en) Treatment of cancer with somatostatin and analogs thereof
US6225444B1 (en) Neuroprotective peptides and uses thereof
CY1107051T1 (el) Αντι-διηθητικα και αντι-αγγειογενετικα θραυσματα ουροκινασης και η χρηση τους
AR002024A1 (es) Proteinas utiles para el tratamiento de la obesidad, composiciones farmaceuticas que incluyen dichas proteinas para tratamientos anti-obesidady procedimiento para prepararlas.
CA2022437A1 (en) Reduced size lhrh analogs
KR102345605B1 (ko) 에리스로포이에틴 유래 펩티드의 세포손상방지에 효과를 통한 활용
US6025471A (en) Diazaspiro, azepino and azabicyclo therapeutic peptides
AU6020099A (en) Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
WO2000021548A3 (en) Angiogenically effective unit dose of fgf and method of administering
JPH10509428A (ja) 活性依存性神経栄養因子の神経栄養ペプチド
HUE026150T2 (en) Inhibitors of apoptosis and uses thereof
EP3966226B1 (en) Masp inhibitory compounds and uses thereof
US4684624A (en) Method of treating cerebral ischemia
DE3882279T2 (de) Zyklisches antikoagulierendes Peptid.
KR880012641A (ko) 아미노산 유도체
WO1997015598A1 (fr) Nouveau peptide
HU198512B (en) Process for producing peptide with anticoagulant effect and pharmaceutical composition comprising same
Feurle et al. Neurokinetic and myokinetic effects of the peptide xenin on the motility of the small and large intestine of guinea pig.
KR100555604B1 (ko) 탁산과 조합된 돌라스태틴-15 유도체
AU630132B2 (en) Anticoagulant peptides
EA007841B1 (ru) Новые пептиды - аналоги гормона высвобождения гормона роста человека
CA2290739A1 (en) New bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy
RU2056432C1 (ru) Производные пептидов или их физиологически приемлемые соли
Mann et al. Rotational syndrome after central injection of C-terminal 7-peptide of cholecystokinin

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase